Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Metabolic reprogramming in renal cancer: Events of a metabolic disease
Samik Chakraborty, Murugabaskar Balan, Akash Sabarwal, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2021) Vol. 1876, Iss. 1, pp. 188559-188559
Open Access | Times Cited: 111

Showing 1-25 of 111 citing articles:

Histopathologic and proteogenomic heterogeneity reveals features of clear cell renal cell carcinoma aggressiveness
Yize Li, T. Mamie Lih, Saravana M. Dhanasekaran, et al.
Cancer Cell (2022) Vol. 41, Iss. 1, pp. 139-163.e17
Open Access | Times Cited: 108
A review of Glycogen Synthase Kinase-3 (GSK3) inhibitors for cancers therapies
Riya Thapa, Gaurav Gupta, Asif Ahmad Bhat, et al.
International Journal of Biological Macromolecules (2023) Vol. 253, pp. 127375-127375
Closed Access | Times Cited: 88
FKBP10 promotes clear cell renal cell carcinoma progression and regulates sensitivity to the HIF2α blockade by facilitating LDHA phosphorylation
Ren Liu, Zhihao Zou, Lingwu Chen, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 16
Understanding Cancer’s Defense against Topoisomerase-Active Drugs: A Comprehensive Review
Nilesh Kumar Sharma, Anjali Bahot, Gopinath Sekar, et al.
Cancers (2024) Vol. 16, Iss. 4, pp. 680-680
Open Access | Times Cited: 16
PI3K/AKT/mTOR Dysregulation and Reprogramming Metabolic Pathways in Renal Cancer: Crosstalk with the VHL/HIF Axis
Silviu Constantin Badoiu, Maria Greabu, Daniela Miricescu, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 9, pp. 8391-8391
Open Access | Times Cited: 33
Metabolic reprogramming of clear cell renal cell carcinoma
Haiyan Zhu, Xin Wang, Shihao Lu, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 26
Nanomaterial-based regulation of redox metabolism for enhancing cancer therapy
Xiaodan Jia, Yue Wang, Yue Qiao, et al.
Chemical Society Reviews (2024)
Closed Access | Times Cited: 9
Role of mammalian target of rapamycin (mTOR) signalling in oncogenesis
Mohamed El‐Tanani, Hamdi Nsairat, Alaa A. A. Aljabali, et al.
Life Sciences (2023) Vol. 323, pp. 121662-121662
Closed Access | Times Cited: 19
Metabolic heterogeneity in clear cell renal cell carcinoma revealed by single-cell RNA sequencing and spatial transcriptomics
Guan‐Wen Yang, Jiangting Cheng, Jiayi Xu, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 8
Serine Metabolic Reprogramming in Tumorigenesis, Tumor Immunity, and Clinical Treatment
Shunxi Wang, Yuan Xiaoxue, Song Guanbin, et al.
Advances in Nutrition (2023) Vol. 14, Iss. 5, pp. 1050-1066
Open Access | Times Cited: 16
Metabolite itaconate in host immunoregulation and defense
Wenchang Yang, Yaxin Wang, Kaixiong Tao, et al.
Cellular & Molecular Biology Letters (2023) Vol. 28, Iss. 1
Open Access | Times Cited: 15
Dichloroacetate for Cancer Treatment: Some Facts and Many Doubts
Tomas Koltai, Larry Fliegel
Pharmaceuticals (2024) Vol. 17, Iss. 6, pp. 744-744
Open Access | Times Cited: 5
Immunomodulation in diabetic wounds healing: The intersection of macrophage reprogramming and immunotherapeutic hydrogels
Dan Sun, Qiang Chang, Feng Lu
Journal of Tissue Engineering (2024) Vol. 15
Open Access | Times Cited: 5
Pathogenic mitochondrial dysfunction and metabolic abnormalities
Walter H. Moos, Douglas V. Faller, Ioannis P. Glavas, et al.
Biochemical Pharmacology (2021) Vol. 193, pp. 114809-114809
Open Access | Times Cited: 31
Iron metabolism: State of the art in hypoxic cancer cell biology
Sai Liu, Xiongfeng Cao, Dongqing Wang, et al.
Archives of Biochemistry and Biophysics (2022) Vol. 723, pp. 109199-109199
Open Access | Times Cited: 22
Glutamine metabolism in cancers: Targeting the oxidative homeostasis
Tengfang Gong, Changbing Zheng, Xidan Ou, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 21
Formation, properties and applications of microalgae-based ZnO nanoparticles: A review
Giang Thanh Tran, Nhu Thi Huynh Nguyen, Ngoan Thi Thao Nguyen, et al.
Journal of environmental chemical engineering (2023) Vol. 11, Iss. 5, pp. 110939-110939
Closed Access | Times Cited: 12
IFI16 promotes the progression of clear cell renal cell carcinoma through the IL6/PI3K/AKT axis
Ke Lü, Yan Zhao, Li Yu, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 4
MDH2 regulates the sensitivity of clear cell renal cell carcinoma to ferroptosis through its interaction with FSP1
Baijie Feng, Wei Su, Xianzhi Guo, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 4
Molecular imaging of renal cell carcinomas: ready for prime time
Qianyun Wu, Hongda Shao, Wei Zhai, et al.
Nature Reviews Urology (2024)
Closed Access | Times Cited: 4
Multiomics Analysis of Exportin Family Reveals XPO1 as a Novel Target for Clear Cell Renal Cell Carcinoma
Yanhong Hao, Huimin Lv, Yan Xu, et al.
International Journal of Genomics (2025) Vol. 2025, Iss. 1
Open Access
Association between folate and glutamine metabolism and prognosis of kidney cancer
Jiaxuan Qin, Chih-Wen Ou-Yang, Xuan Zhuang
Frontiers in Nutrition (2025) Vol. 11
Open Access
Identification of hub genes, non-coding RNAs and pathways in Renal cell carcinoma (RCC): A comprehensive in silico study
Ahmad Golestanifar, Hengameh Khedri, Parisa Noorabadi, et al.
Biochemistry and Biophysics Reports (2025) Vol. 41, pp. 101942-101942
Open Access
K-Means Clustering of Hyperpolarised 13C-MRI Identifies Intratumoral Perfusion/Metabolism Mismatch in Renal Cell Carcinoma as the Best Predictor of the Highest Grade
Ines Horvat‐Menih, Alixander S. Khan, Mary A. McLean, et al.
Cancers (2025) Vol. 17, Iss. 4, pp. 569-569
Open Access
Metabolic signature of renal cell carcinoma tumours and its correlation with the urinary metabolome
Filipa Amaro, Márcia Carvalho, Carina Carvalho‐Maia, et al.
Metabolomics (2025) Vol. 21, Iss. 2
Closed Access
Page 1 - Next Page

Scroll to top